Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H21ClN2S |
Molecular Weight | 344.901 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCN(CC1)C2CC3=CC=CC=C3SC4=C2C=C(Cl)C=C4
InChI
InChIKey=XRYLGRGAWQSVQW-UHFFFAOYSA-N
InChI=1S/C19H21ClN2S/c1-21-8-10-22(11-9-21)17-12-14-4-2-3-5-18(14)23-19-7-6-15(20)13-16(17)19/h2-7,13,17H,8-12H2,1H3
Molecular Formula | C19H21ClN2S |
Molecular Weight | 344.901 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Clorotepine (aka octoclothepin or octoclothepine) is an antipsychotic from the tricyclic group derived from perathiepin. It was originally developed in 1965 and marketed in the Czech Republic by Spofa in or around 1971 for the treatment of schizophrenic psychosis. Clorotepine has a high affinity for the dopamine (D1, D2, D3, D4), receptors the serotonin 5-HT (2A, 2B, 2C, 6, 7) receptors, the alpha-adrenergic receptors (1A, 1B, 1D), and the histamine H1 receptors. In most instances, it acts as an antagonist (or inverse agonist). Clorotepine will also block the reuptake of norepinephrine by inhibiting the norepinephrine transporter.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P28223 Gene ID: 3356.0 Gene Symbol: HTR2A Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/1676758 |
0.57 nM [IC50] | ||
Target ID: P35348|||B0ZBD9|||Q6RUJ8 Gene ID: 148.0 Gene Symbol: ADRA1A Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/1676758 |
0.18 nM [IC50] | ||
Target ID: P21728 Gene ID: 1812.0 Gene Symbol: DRD1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/1676758 |
2.2 nM [IC50] | ||
Target ID: P14416 Gene ID: 1813.0 Gene Symbol: DRD2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/1676758 |
2.4 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Clotepin Approved UseUnknown |
|||
Primary | Clotepin Approved UseUnknown |
|||
Primary | Clotepin Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Neuroleptics related to butaclamol. An investigation of the effects of chlorine substituents on the aromatic rings. | 1978 Dec |
|
Further clinical experiences with optical isomers of the L and D clorothepin. | 1979 |
|
On acute effects of some drugs on the higher nervous activity in man. Clorotepin (2 mg), its (+)-enantiomer (2 mg) and (-)-enantiomer (2 mg). | 1980 |
|
Octoclothepin enantiomers. A reinvestigation of their biochemical and pharmacological activity in relation to a new receptor-interaction model for dopamine D-2 receptor antagonists. | 1991 Jul |
|
Molecular field analysis of clozapine analogs in the development of a pharmacophore model of antipsychotic drug action. | 2001 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6231812
Clorotepin is provided in doses up to 2 mg.
Route of Administration:
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:30:50 GMT 2023
by
admin
on
Fri Dec 15 16:30:50 GMT 2023
|
Record UNII |
E65W20MU7A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66883
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1238
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
PRIMARY | |||
|
E65W20MU7A
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
PRIMARY | |||
|
Clorotepine
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
PRIMARY | |||
|
3423
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
PRIMARY | |||
|
100000084010
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
PRIMARY | |||
|
DTXSID7048451
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
PRIMARY | |||
|
13448-22-1
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
PRIMARY | |||
|
CHEMBL64249
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
PRIMARY | |||
|
C100288
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
PRIMARY | |||
|
C77572
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
PRIMARY | |||
|
3912
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
PRIMARY | |||
|
SUB06765MIG
Created by
admin on Fri Dec 15 16:30:50 GMT 2023 , Edited by admin on Fri Dec 15 16:30:50 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |